Glucagon-Like Peptide-1 Receptor Agonists for Chronic Weight Management.

Adv Med · 2023 · PMC10533252 · PMID 37771634

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a worrying trendno p-value reported

While many studies have demonstrated efficacy in patients with diabetes and obesity, a worrying trend is interest in Ozempic for cosmetic weight loss popularized by social media and celebrity influences [ 48 ].

also in 304 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.